BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28850619)

  • 1. The stability of Fbw7α in M-phase requires its phosphorylation by PKC.
    Zitouni S; Méchali F; Papin C; Choquet A; Roche D; Baldin V; Coux O; Bonne-Andrea C
    PLoS One; 2017; 12(8):e0183500. PubMed ID: 28850619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the tumour suppressor Fbw7α by PKC-dependent phosphorylation and cancer-associated mutations.
    Durgan J; Parker PJ
    Biochem J; 2010 Nov; 432(1):77-87. PubMed ID: 20815813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.
    Trausch-Azar JS; Abed M; Orian A; Schwartz AL
    J Cell Physiol; 2015 Apr; 230(4):842-52. PubMed ID: 25204433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
    Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
    Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbw7α and Fbw7γ collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation.
    Bhaskaran N; van Drogen F; Ng HF; Kumar R; Ekholm-Reed S; Peter M; Sangfelt O; Reed SI
    Mol Cell Biol; 2013 Jan; 33(1):85-97. PubMed ID: 23109421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase.
    Grim JE; Gustafson MP; Hirata RK; Hagar AC; Swanger J; Welcker M; Hwang HC; Ericsson J; Russell DW; Clurman BE
    J Cell Biol; 2008 Jun; 181(6):913-20. PubMed ID: 18559665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity.
    Schülein C; Eilers M; Popov N
    FEBS Lett; 2011 Jul; 585(14):2151-7. PubMed ID: 21620836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation.
    Kumar Y; Kapoor I; Khan K; Thacker G; Khan MP; Shukla N; Kanaujiya JK; Sanyal S; Chattopadhyay N; Trivedi AK
    J Biol Chem; 2015 Dec; 290(52):30975-87. PubMed ID: 26542806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
    Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
    Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbw7 isoform interaction contributes to cyclin E proteolysis.
    Zhang W; Koepp DM
    Mol Cancer Res; 2006 Dec; 4(12):935-43. PubMed ID: 17189384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).
    Bialkowska AB; Liu Y; Nandan MO; Yang VW
    J Biol Chem; 2014 Feb; 289(9):5997-6005. PubMed ID: 24398687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases.
    Hao B; Oehlmann S; Sowa ME; Harper JW; Pavletich NP
    Mol Cell; 2007 Apr; 26(1):131-43. PubMed ID: 17434132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor.
    Tripathi V; Kaur E; Kharat SS; Hussain M; Damodaran AP; Kulshrestha S; Sengupta S
    J Biol Chem; 2019 Sep; 294(36):13224-13232. PubMed ID: 31346036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
    Zhao D; Zheng HQ; Zhou Z; Chen C
    Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the ubiquitin ligase Fbw7 in cancer progression.
    Cheng Y; Li G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
    Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
    Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression of c-Jun's E3 ubiquitin ligases contributes to c-Jun induction by UV.
    Anzi S; Finkin S; Shaulian E
    Cell Signal; 2008 May; 20(5):862-71. PubMed ID: 18295447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Krüppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor γ2 (PPARγ2) pathway but not SREBP-1c protein in mice.
    Kumadaki S; Karasawa T; Matsuzaka T; Ema M; Nakagawa Y; Nakakuki M; Saito R; Yahagi N; Iwasaki H; Sone H; Takekoshi K; Yatoh S; Kobayashi K; Takahashi A; Suzuki H; Takahashi S; Yamada N; Shimano H
    J Biol Chem; 2011 Nov; 286(47):40835-46. PubMed ID: 21911492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphorylation-dependent regulation of nuclear SREBP1 during mitosis links lipid metabolism and cell growth.
    Bengoechea-Alonso MT; Ericsson J
    Cell Cycle; 2016 Oct; 15(20):2753-65. PubMed ID: 27579997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitotic phosphorylation of Bloom helicase at Thr182 is required for its proteasomal degradation and maintenance of chromosomal stability.
    Kharat SS; Tripathi V; Damodaran AP; Priyadarshini R; Chandra S; Tikoo S; Nandhakumar R; Srivastava V; Priya S; Hussain M; Kaur S; Fishman JB; Sengupta S
    Oncogene; 2016 Feb; 35(8):1025-38. PubMed ID: 26028025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.